A functional variant at a prostate cancer predisposition locus at 8q24 is associated with PVT1 expression

PLoS Genetics

Volumn 7, Issue 7, 2011, Pages

  Meyer, Kerstin B ^a   Maia, Ana Teresa ^a,b   O'Reilly, Martin ^a   Ghoussaini, Maya ^b   Prathalingam, Radhika ^a   Porter Gill, Patricia ^c   Ambs, Stefan ^c   Prokunina Olsson, Ludmila ^c   Carroll, Jason ^a,b   Ponder, Bruce A J ^a,b  

^a CANCER RESEARCH UK CAMBRIDGE RESEARCH INSTITUTE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYRIBONUCLEASE I; FIBROBLAST GROWTH FACTOR 2; TRANSCRIPTION FACTOR YY1; UNTRANSLATED RNA;

ALLELE; ARTICLE; BINDING SITE; CANCER CELL CULTURE; CANCER RISK; CANCER SUSCEPTIBILITY; CHROMATIN STRUCTURE; CHROMOSOME 8Q; CONTROLLED STUDY; COPY NUMBER VARIATION; FUNCTIONAL GENOMICS; GENE ACTIVITY; GENE EXPRESSION REGULATION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE MAPPING; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; ONCOGENE; ONCOGENE MYC; PROMOTER REGION; PROSTATE CANCER; PROTEIN BINDING; PROTEIN DNA BINDING; PVT1 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION INITIATION; BIOLOGICAL MODEL; BREAST TUMOR; CELL STRAIN HCT116; CHROMOSOME 8; COLON TUMOR; CONSENSUS SEQUENCE; FEMALE; GENETIC PREDISPOSITION; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; PROSTATE TUMOR; TUMOR CELL LINE;

ALLELES; BASE SEQUENCE; BINDING SITES; BREAST NEOPLASMS; CELL LINE, TUMOR; CHROMOSOMES, HUMAN, PAIR 8; COLONIC NEOPLASMS; CONSENSUS SEQUENCE; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HCT116 CELLS; HUMANS; MALE; MODELS, BIOLOGICAL; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS; RNA, UNTRANSLATED; TRANSCRIPTIONAL ACTIVATION; YY1 TRANSCRIPTION FACTOR;

EID: 79960956864     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1002165     Document Type: Article

References (42)

1. Ghoussaini M, Song H, Koessler T, Al Olama AA, Kote-Jarai Z, et al. (2008) Multiple loci with different cancer specificities within the 8q24 gene desert. J Natl Cancer Inst 100: 962-966.
2. Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, et al. (2007) Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447: 1087-1093.
3. Al Olama AA, Kote-Jarai Z, Giles GG, Guy M, Morrison J, et al. (2009) Multiple loci on 8q24 associated with prostate cancer susceptibility. Nat Genet 41: 1058-1060.
4. Kiemeney LA, Thorlacius S, Sulem P, Geller F, Aben KK, et al. (2008) Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. Nat Genet 40: 1307-1312.
5. Crowther-Swanepoel D, Broderick P, Di Bernardo MC, Dobbins SE, Torres M, et al. (2010) Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk. Nat Genet 42: 132-136.
6. Yeager M, Chatterjee N, Ciampa J, Jacobs KB, Gonzalez-Bosquet J, et al. (2009) Identification of a new prostate cancer susceptibility locus on chromosome 8q24. Nat Genet 41: 1055-1057.
7. Gudmundsson J, Sulem P, Gudbjartsson DF, Blondal T, Gylfason A, et al. (2009) Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility. Nat Genet 41: 1122-1126.
8. Lin S, Ding J, (2009) Integration of ranked lists via cross entropy Monte Carlo with applications to mRNA and microRNA Studies. Biometrics 65: 9-18.
9. Liu W, Xie CC, Zhu Y, Li T, Sun J, et al. (2008) Homozygous deletions and recurrent amplifications implicate new genes involved in prostate cancer. Neoplasia 10: 897-907.
10. Guan Y, Kuo WL, Stilwell JL, Takano H, Lapuk AV, et al. (2007) Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer. Clin Cancer Res 13: 5745-5755.
11. Beck-Engeser GB, Lum AM, Huppi K, Caplen NJ, Wang BB, et al. (2008) Pvt1-encoded microRNAs in oncogenesis. Retrovirology 5: 4.
12. Adhikary S, Eilers M, (2005) Transcriptional regulation and transformation by myc proteins. Nature Reviews Molecular Cell Biology 6: 635-645.
13. Huppi K, Volfovsky N, Runfola T, Jones TL, Mackiewicz M, et al. (2008) The identification of microRNAs in a genomically unstable region of human chromosome 8q24. Mol Cancer Res 6: 212-221.
14. Pomerantz MM, Ahmadiyeh N, Jia L, Herman P, Verzi MP, et al. (2009) The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer. Nat Genet 41: 882-884.
15. Tuupanen S, Turunen M, Lehtonen R, Hallikas O, Vanharanta S, et al. (2009) The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling. Nat Genet 41: 885-890.
16. Wasserman NF, Aneas I, Nobrega MA, (2010) An 8q24 gene desert variant associated with prostate cancer risk confers differential in vivo activity to a MYC enhancer. Genome Res 20: 1191-1197.
17. Jia L, Landan G, Pomerantz M, Jaschek R, Herman P, et al. (2009) Functional enhancers at the gene-poor 8q24 cancer-linked locus. PLoS Genet 5: e1000597 doi:10.1371/journal.pgen.1000597.
18. Pomerantz MM, Beckwith CA, Regan MM, Wyman SK, Petrovics G, et al. (2009) Evaluation of the 8q24 prostate cancer risk locus and MYC expression. Cancer Res 69: 5568-5574.
19. Prokunina-Olsson L, Hall JL, (2009) No effect of cancer-associated SNP rs6983267 in the 8q24 region on co-expression of MYC and TCF7L2 in normal colon tissue. Mol Cancer 8: 96.
20. Wright JB, Brown SJ, Cole MD, (2010) Upregulation of c-MYC in cis through a large chromatin loop linked to a cancer risk-associated single-nucleotide polymorphism in colorectal cancer cells. Mol Cell Biol 30: 1411-1420.
21. Boyle AP, Davis S, Shulha HP, Meltzer P, Margulies EH, et al. (2008) High-resolution mapping and characterization of open chromatin across the genome. Cell 132: 311-322.
22. Udler MS, Meyer KB, Pooley KA, Karlins E, Struewing JP, et al. (2009) FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation. Hum Mol Genet 18: 1692-1703.
23. Udler MS, Ahmed S, Healey CS, Meyer K, Struewing J, et al. (2010) Fine scale mapping of the breast cancer 16q12 locus. Hum Mol Genet 19: 2507-2515.
24. Schmidt D, Schwalie PC, Ross-Innes CS, Hurtado A, Brown GD, et al. (2010) A CTCF-independent role for cohesin in tissue-specific transcription. Genome Res 20: 578-588.
25. Turnbull C, Ahmed S, Morrison J, Pernet D, Renwick A, et al. (2010) Genome-wide association study identifies five new breast cancer susceptibility loci. (2010). Nat Genet 42: 504-507.
26. Thomas MJ, Seto E, (1999) Unlocking the mechanisms of transcription factor YY1: are chromatin modifying enzymes the key? Gene 236: 197-208.
27. Breslin MB, Vedeckis WV, (1998) The human glucocorticoid receptor promoter upstream sequences contain binding sites for the ubiquitous transcription factor, Yin Yang 1. J Steroid Biochem Mol Biol 67: 369-381.
28. Gordon S, Akopyan G, Garban H, Bonavida B, (2006) Transcription factor YY1: structure, function, and therapeutic implications in cancer biology. Oncogene 25: 1125-1142.
29. Ahmadiyeh N, Pomerantz MM, Grisanzio C, Herman P, Jia L, et al. (2010) 8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC. Proc Natl Acad Sci U S A 107: 9742-9746.
30. Seligson D, Horvath S, Huerta-Yepez S, Hanna S, Garban H, et al. (2005) Expression of transcription factor Yin Yang 1 in prostate cancer. Int J Oncol 27: 131-141.
31. Hurtado A, Holmes KA, Ross-Innes CS, Schmidt D, Carroll JS, (2011) FOXA1 is a key determinant of estrogen receptor function and endocrine response. Nat Genet 43: 11-12.
32. Asker C, Mareni C, Coviello D, Ingvarsson S, Sessarego M, et al. (1988) Amplification of c-myc and pvt-1 homologous sequences in acute nonlymphatic leukemia. Leuk Res 12: 523-527.
33. Bakkus MH, Brakel-van Peer KM, Michiels JJ, van 't Veer MB, Benner R, (1990) Amplification of the c-myc and the pvt-like region in human multiple myeloma. Oncogene 5: 1359-1364.
34. Graham M, Adams JM, (1986) Chromosome 8 breakpoint far 3′ of the c-myc oncogene in a Burkitt's lymphoma 2;8 variant translocation is equivalent to the murine pvt-1 locus. EMBO J 5: 2845-2851.
35. Carramusa L, Contino F, Ferro A, Minafra L, Perconti G, et al. (2007) The PVT-1 oncogene is a Myc protein target that is overexpressed in transformed cells. J Cell Physiol 213: 511-518.
36. Enciso-Mora V, Broderick P, Ma Y, Jarrett RF, Hjalgrim H, et al. (2010) A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3). Nat Genet 42: 1126-1130.
37. Li H, Durbin R, (2009) Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25: 1754-1760.
38. Dekker J, Rippe K, Dekker M, Kleckner N, (2002) Capturing chromosome conformation. Science 295: 1306-1311.
39. West AG, Fraser P, (2005) Remote control of gene transcription. Hum Mol Genet 14 Spec No 1: R101-111.
40. Meyer KB, Maia AT, O'Reilly M, Teschendorff AE, Chin SF, et al. (2008) Allele-specific up-regulation of FGFR2 increases susceptibility to breast cancer. PLoS Biol 6: e108 doi:10.1371/journal.pbio.0060108.
41. Schmidt D, Wilson MD, Spyrou C, Brown GD, Hadfield J, et al. (2009) ChIP-seq: using high-throughput sequencing to discover protein-DNA interactions. Methods 48: 240-248.
42. Kim J, Kollhoff A, Bergmann A, Stubbs L, (2003) Methylation-sensitive binding of transcription factor YY1 to an insulator sequence within the paternally expressed imprinted gene, Peg3. Hum Mol Genet 12: 233-245.